These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5302304)

  • 1. Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan.
    Benenson AS; Saad A; Mosley WH; Ahmed A
    Bull World Health Organ; 1968; 38(2):287-95. PubMed ID: 5302304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae.
    Mosley WH; McCormack WM; Ahmed A; Chowdhury AK; Barui RK
    Bull World Health Organ; 1969; 40(2):187-97. PubMed ID: 5306539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients.
    Mosley WH; Ahmad S; Benenson AS; Ahmed A
    Bull World Health Organ; 1968; 38(5):777-85. PubMed ID: 5303331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.
    Mosley WH; Benenson AS; Barui R
    Bull World Health Organ; 1968; 38(3):327-34. PubMed ID: 5302327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate.
    Mosley WH; Benenson AS; Barui R
    Bull World Health Organ; 1968; 38(3):335-46. PubMed ID: 5302923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.
    Benenson AS; Saad A; Mosley WH
    Bull World Health Organ; 1968; 38(2):277-85. PubMed ID: 5302303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological studies in cholera. I. Vibrio agglutinin response of cholera patients determined by a microtechnique.
    Benenson AS; Saad A; Paul M
    Bull World Health Organ; 1968; 38(2):267-76. PubMed ID: 5302302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 3. The lack of effect of prior vaccination or circulating vibriocidal antibody on the severity of clinical cholera.
    McCormack WM; Rahman AS; Chowdhury AK; Mosley WH; Phillips RA
    Bull World Health Organ; 1969; 40(2):199-204. PubMed ID: 5306540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of the vascular permeability factor of Vibrio Cholerae in man.
    Martin AR; Vernon TM; Mosley WH
    Am J Trop Med Hyg; 1969 Mar; 18(2):253-7. PubMed ID: 5777737
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field.
    Benenson AS; Mosley WH; Fahimuddin M; Oseasohn RO
    Bull World Health Organ; 1968; 38(3):359-72. PubMed ID: 5302329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of vibriocidal antibody research in endemic areas of Vibrio cholerae 0:1].
    Bendib A; Bougoudogo F; Messast M; Rezkallah D; Hamchi L; Bellouche Y; Aidoud NS; Keddouri A; Fournier JM; Dodin A
    Bull Soc Pathol Exot; 1994; 87(1):33-7. PubMed ID: 8003902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consecutive outbreaks of Vibrio cholerae O139 and V. cholerae O1 cholera in a fishing village near Karachi, Pakistan.
    Siddiqui FJ; Bhutto NS; von Seidlein L; Khurram I; Rasool S; Ali M; Zafar A; Deen JL; Clemens JD; Nizami Q; Bhutta ZA
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):476-82. PubMed ID: 16443247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine.
    Glass RI; Svennerholm AM; Stoll BJ; Khan MR; Huda S; Huq MI; Holmgren J
    Pediatr Infect Dis J; 1989 Feb; 8(2):105-9. PubMed ID: 2704600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological studies on cholera patients and their household contacts in Calcutta in 1968. Joint ICMR-GWB-WHO Cholera Study Group, Calcutta, India.
    Joint ICMR-GWB-WHO Cholera Study Group
    Bull World Health Organ; 1970; 43(3):389-99. PubMed ID: 5312993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vibriocidal antibody and antibodies to Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in Thai population.
    Chongsa-nguan M; Chaicumpa W; Kalambaheti T; Soejoedi H; Luxananil P; Swasdikosa S; Thanasiri P; Mayurasakorn S
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):558-66. PubMed ID: 3576285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the serum vibriocidal and agglutinating antibodies in cholera cases and in normal residents of the endemic and non-endemic cholera areas.
    Ahmed A; Bhattacharjee AK; Mosley WH
    J Immunol; 1970 Aug; 105(2):431-41. PubMed ID: 5433700
    [No Abstract]   [Full Text] [Related]  

  • 19. [A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine (author's transl)].
    Gateff C; Dodin A; Wiart J
    Ann Microbiol (Paris); 1975; 126(2):231-46. PubMed ID: 1098542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vibriocidal titre in cholera cases and contacts: its value in assessing endemicity of or susceptibility to cholera.
    Khan MU; Barua DK; Begum T; Shahidullah M
    Trop Geogr Med; 1987 Jul; 39(3):271-5. PubMed ID: 3433343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.